- Company
- History
- Management
- Investment
- Job vacancies
In April 2008, Seraphim Capital, the £30m Enterprise Capital Fund led a £2million round of investment into Sirigen, co-investing alongside Oxford Capital Partners. Great Pacific Capital an earlier investor retains a stake in the Company and representation on Sirigen’s Board. The investment will enables Sirigen to continue to exploit its technology across the $47billion biomedical industry.
Seraphim Capital
Seraphim is a consortium of Business Angel networks and corporate venturers across the UK, who have joined forces to raise £10m of private investment, with £20m of UK Government backing, to manage one of the UKs new Enterprise Capital Funds.
Seraphim's partners include Business Angel networks from the South East of England represented by London Business Angels and Pi Capital, Advantage Business Angels in the Midlands, in the North through Entrust and in Scotland through Archangels. The corporate venturers involved are General Capital Venture Finance, The Summit Group and GLE. An exciting dimension to the Fund consortium is the addition of funding from Focus Enterprises a US investment bank and New Vantage Group one of the leading US Angel Groups.
The structure of the Seraphim partnership has created an extensive network, particularly within the UK but also globally. The Fund has strong connections with leading businessmen and other investor groups which provide access to a range of financial assistance. The Fund also has good connections across a range of commercial and professional companies which can provide young companies with introductions to help their businesses. In addition, the Fund encourages interaction between our portfolio companies to share solutions to problems and new ideas.
Seraphim's choice of an 'Angel-led' structure for its Fund reflects the fact that each investor wishes to be party to the investment decisions, in contrast to most conventional managed fund schemes. Each investor partner has nominated a representative to the Investment Board, which is directly and actively engaged in making investment decisions on behalf of the Fund.
Oxford Capital Partners
Oxford Capital Partners is a venture capital firm working on behalf of institutional and private investors.
Its focus is on emerging science and technology and its expertise lies in accelerating businesses with potential for high growth in global markets. Oxford Capital Partners looks for the best opportunities, backing exceptional management teams and investing across all stages of development, from start-up to IPO.
Leveraging its extensive world-wide networks, Oxford Capital Partners assists portfolio companies in accessing international markets in Europe, North America, Middle East and Asia.
Oxford Capital Partners manages several funds and oversees a portfolio of companies in a range of technology sectors, including sustainability technologies, communication technologies and healthcare.
Great Pacific Capital
The Santa Barbara and Ventura County region has a growing base of engineering and technology expertise resulting in a fertile environment of high-quality
start-ups seeking capital. Great Pacific Capital invests locally in new opportunities in the life sciences, information, manufacturing, services and media; all benefiting from applied technology.
Great Pacific Capital consider the region can absorb significantly more local investment than is currently being deployed.
R egional focus provides direct investor access to new ventures and direct entrepreneur access to organized, aggregated local capital. Investors and entrepreneurs both benefit from dedicated fund managers applying a high-touch approach with 'start-up to exit' experience.
Investment Profile
Investment is usually between proof of concept and positive cash flow. First revenue is usually squarely in-between these two milestones. Investment size varies from $500K to $3M. Most investments are regional and board representation is typically sought.